Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Kidney (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Not applicableEnded earlyNCT02026960
What this trial is testing

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

Who this might be right for
Metastatic Renal Cell CarcinomaGenitourinary Cancer (Bladder, Prostate or Testicular)
Duke University 14
Not applicableStudy completedNCT00531544
What this trial is testing

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

Who this might be right for
Metastatic Renal Cell Carcinoma
King Faisal Specialist Hospital & Research Center 350
Testing effectiveness (Phase 2)Study completedNCT00003308
What this trial is testing

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT02187042
What this trial is testing

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

Who this might be right for
Metastatic/Advanced Renal Cell Carcinoma
Pfizer 70
Testing effectiveness (Phase 2)Ended earlyNCT04955743
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Who this might be right for
MelanomaRenal Cell CarcinomaBrain Metastases+4 more
Yale University 18
Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Not applicableStudy completedNCT03670992
What this trial is testing

Surgical Treatment of Pancreatic RCC Metastases

Who this might be right for
Renal Cell CarcinomaMetastases, Neoplasm
Azienda Policlinico Umberto I 26
Testing effectiveness (Phase 2)Study completedNCT00586495
What this trial is testing

Long-term Extension From RCC Phase II (11515)

Who this might be right for
Carcinoma, Renal Cell
Bayer 95